Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:08 AM
Study NCT ID:
NCT03403634
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2018-01-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-29
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-11
First Submit QC Date:
None
Study First Post Date:
2018-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-11-01
Results First Submit QC Date:
None
Results First Post Date:
2022-03-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-25
Last Update Post Date:
2022-03-02
Last Update Post Date Type:
ACTUAL